Emiko Sugawara

1.1k citations
20 papers · 722 indexed · h-index 11
Topics
Bladder and Urothelial Cancer Treatments (6 papers)Renal cell carcinoma treatment (5 papers)Renal and related cancers (5 papers)
Partner nations
JapanCzechiaIndia

In The Last Decade

Emiko Sugawara

17 papers receiving 702 citations

Peers

Emiko Sugawara
Comparison fields: 5 of 59
  • Pulmonary and Respiratory Medicine 356
  • Molecular Biology 306
  • Oncology 236
  • Plant Science 152
  • Cancer Research 142
Replace Eric Routhier with:
Eric Routhier United States
Violaine Bourdon France
Sarah N. Salm United States
Naveed Ishaque Germany
Raúl Peña Spain
Jieqiong Deng China
Twinkal C. Pansuriya Netherlands
Jing‐Fang Lu United States
Marei Dose United States
Caroline Braem Belgium
Emiko Sugawara relative to Eric Routhier United States Eric Routhier's profile →
Citations per field
00.5×5.4×
Eric Routhier · 1×
Citations per year

Countries citing papers authored by Emiko Sugawara

Since Specialization
Citations

This map shows the geographic impact of Emiko Sugawara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emiko Sugawara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emiko Sugawara more than expected).

Fields of papers citing papers by Emiko Sugawara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emiko Sugawara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emiko Sugawara. The network helps show where Emiko Sugawara may publish in the future.

Co-authorship network of co-authors of Emiko Sugawara

This figure shows the co-authorship network connecting the top 25 collaborators of Emiko Sugawara. A scholar is included among the top collaborators of Emiko Sugawara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emiko Sugawara. Emiko Sugawara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 2
5 1
6 0
7 17
8 4
9 4
10 25
11 18
12 21
13 44
14 205
15 103
16 16
17 77
18 21
19 2
20 160

About Emiko Sugawara

Emiko Sugawara is a scholar working on Urology, Pulmonary and Respiratory Medicine and Oncology, having authored 20 papers that have together received 722 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Renal cell carcinoma treatment (5 papers) and Renal and related cancers (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (356 citations), Cancer Research (142 citations) and Oncology (236 citations). Emiko Sugawara has collaborated with scholars based in Japan, Czechia and India. Frequent co-authors include Kengo Takeuchi, Reimi Asaka, Satoko Hatano, Hiroyuki Mano, Yuki Togashi, Seiji Sakata, Manabu Soda, Takashi Nakajima, Yuichi Ishikawa and Nobuyuki Yoshikawa. Their work appears in journals such as PLoS ONE, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026